[在PICC导管治疗后持续出血的患者中应用新型功能性静血包裹的进展]
Jimin Wu1, Qiong Yan1, Haiying Xu1
1Xiangyang Central Hospital, Xiangyang, 441000.
概括
在外围插入中心导管 (PICC) 程序中选择有效的静血包对于预防出血并发症至关重要. 本综述详细介绍了新型带及其机制,以帮助医务人员进行选择.
科学领域:
- 医疗器械 医疗器械
- 生物材料是一种生物材料.
- 血管接入 血管接入
背景情况:
- 流血 周周插入中央导管 (PICC) 放置后会增加感染和意外切除的风险.
- 静脉带对于尽量减少导管过程中血液透至关重要.
- 多种新型的止血带对临床选择构成挑战.
研究的目的:
- 引入新的功能性静血带及其特征.
- 在PICC程序中审查特定敷料 (奇托桑,蓝酸,酸盐,凝海绵,氧纤维素) 的静血机制和作用.
- 为了展望功能性静血带的未来发展.
主要方法:
- 关于新型功能性静血带的文献评论.
- 对基托,烯酸,酸盐,凝海绵和氧纤维素料的静血机制和临床影响的分析.
- 讨论这些敷料在PICC穿孔部位的应用.
主要成果:
- 详细介绍各种新型血液静止带及其特性.
- 关于奇托,蓝酸,酸盐,凝海绵和氧纤维素的血静疗效的具体见解.
- 识别在选择适合PICC的静血带时面临的挑战.
结论:
- 有效地使用止血可以减轻PICC相关的出血和相关风险.
- 了解新型包裹的机制有助于做出明智的临床选择.
- 未来的静血预计将是多功能和复合材料.
相关概念视频
Introduction to Hemostasis
4.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
Extrinsic and Intrinsic Pathways of Hemostasis
3.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.6K
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Formation of the Platelet Plug
2.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.8K
Esophageal Varices-II: Clinical Features and Management
24
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
24


